Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 95.27 billion. The enterprise value is 110.09 billion.
| Market Cap | 95.27B |
| Enterprise Value | 110.09B |
Important Dates
The last earnings date was Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | May 5, 2026 |
Share Statistics
Sanofi has 1.21 billion shares outstanding. The number of shares has decreased by -2.73% in one year.
| Current Share Class | 1.21B |
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | -2.73% |
| Shares Change (QoQ) | -0.70% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 47.34% |
| Float | 1.09B |
Valuation Ratios
The trailing PE ratio is 19.90 and the forward PE ratio is 9.13. Sanofi's PEG ratio is 1.07.
| PE Ratio | 19.90 |
| Forward PE | 9.13 |
| PS Ratio | 2.01 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 25.60 |
| P/FCF Ratio | 11.11 |
| P/OCF Ratio | 9.21 |
| PEG Ratio | 1.07 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.53, with an EV/FCF ratio of 12.83.
| EV / Earnings | 14.57 |
| EV / Sales | 2.32 |
| EV / EBITDA | 8.53 |
| EV / EBIT | 11.57 |
| EV / FCF | 12.83 |
Financial Position
The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.01 |
| Quick Ratio | 0.20 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.53 |
| Debt / FCF | 2.33 |
| Interest Coverage | 18.84 |
Financial Efficiency
Return on equity (ROE) is 6.43% and return on invested capital (ROIC) is 9.38%.
| Return on Equity (ROE) | 6.43% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.38% |
| Return on Capital Employed (ROCE) | 9.90% |
| Weighted Average Cost of Capital (WACC) | 5.34% |
| Revenue Per Employee | 632,686 |
| Profits Per Employee | 100,941 |
| Employee Count | 74,846 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Sanofi has paid 982.00 million in taxes.
| Income Tax | 982.00M |
| Effective Tax Rate | 16.83% |
Stock Price Statistics
The stock price has decreased by -14.58% in the last 52 weeks. The beta is 0.32, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -14.58% |
| 50-Day Moving Average | 79.53 |
| 200-Day Moving Average | 82.38 |
| Relative Strength Index (RSI) | 42.91 |
| Average Volume (20 Days) | 2,341,476 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 47.35 billion and earned 7.56 billion in profits. Earnings per share was 6.20.
| Revenue | 47.35B |
| Gross Profit | 34.26B |
| Operating Income | 9.70B |
| Pretax Income | 5.83B |
| Net Income | 7.56B |
| EBITDA | 12.83B |
| EBIT | 9.70B |
| Earnings Per Share (EPS) | 6.20 |
Balance Sheet
The company has 5.54 billion in cash and 20.02 billion in debt, giving a net cash position of -14.48 billion or -11.99 per share.
| Cash & Cash Equivalents | 5.54B |
| Total Debt | 20.02B |
| Net Cash | -14.48B |
| Net Cash Per Share | -11.99 |
| Equity (Book Value) | 73.14B |
| Book Value Per Share | 60.46 |
| Working Capital | 156.00M |
Cash Flow
In the last 12 months, operating cash flow was 10.34 billion and capital expenditures -1.76 billion, giving a free cash flow of 8.58 billion.
| Operating Cash Flow | 10.34B |
| Capital Expenditures | -1.76B |
| Depreciation & Amortization | 3.12B |
| Net Borrowing | 1.50B |
| Free Cash Flow | 8.58B |
| FCF Per Share | 7.10 |
Margins
Gross margin is 72.36%, with operating and profit margins of 20.49% and 15.95%.
| Gross Margin | 72.36% |
| Operating Margin | 20.49% |
| Pretax Margin | 12.32% |
| Profit Margin | 15.95% |
| EBITDA Margin | 27.09% |
| EBIT Margin | 20.49% |
| FCF Margin | 18.11% |
Dividends & Yields
This stock pays an annual dividend of 4.12, which amounts to a dividend yield of 5.22%.
| Dividend Per Share | 4.12 |
| Dividend Yield | 5.22% |
| Dividend Growth (YoY) | 5.10% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 63.16% |
| Buyback Yield | 2.73% |
| Shareholder Yield | 7.88% |
| Earnings Yield | 7.93% |
| FCF Yield | 9.00% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |